Remedy Entertainment Plc: Share subscriptions based on stock options 2018 and 2019

Report this content

Remedy Entertainment Plc     Stock exchange release       July 1, 2024, 9:00 a.m. EEST

 

Share subscriptions based on stock options 2018 and 2019

Between April 1 and May 31, 2024, a total of 16,500 Remedy Entertainment Plc’s new shares has been subscribed for with the company’s stock options 2018 and 2019. For subscriptions made with the stock options 2018 and 2019, the entire subscription price of EUR 120,250.00 will be entered in the reserve for invested unrestricted equity.

After the trade registration the total amount of shares is 13,569,151.

The shares subscribed for under the stock options 2018 and 2019 have been registered in the Trade Register on July 1, 2024, as of which date the new shares will establish shareholder rights. The shares will be traded on the official list of Nasdaq Helsinki Ltd together with the old shares as of July 2, 2024.

The shares subscription period for stock options 2018 started on 1 June 2021 and ended on 31 May 2024.

The shares subscription period for stock options 2019 started on 1 June 2022 and will end on 31 May 2025.

The terms and conditions of stock options 2018 and 2019 with additional information are available on the company's website at https://investors.remedygames.com/remuneration/

Remedy Entertainment Plc

 

More Information

Liisa Eloranta, Senior Investor Relations Specialist
Phone: +358 50 4334992
Email: liisa.eloranta@remedygames.com
 

Remedy in brief

Remedy Entertainment Plc is a pioneering, globally renowned video game company founded in 1995 and headquartered in Finland with an office in Stockholm, Sweden. Known for its story-driven and visually stunning action games, Remedy has created multiple successful, critically acclaimed franchises such as Control, Alan Wake and Max Payne. Remedy also develops its own Northlight game engine and tools technology that powers many of its games. Remedy’s shares are listed on Nasdaq Helsinki’s official list. www.remedygames.com

Subscribe